Regional cerebral blood flow and negative/positive symptoms in 24 drug- naive schizophrenics

Journal of Nuclear Medicine

Volumn 38, Issue 2, 1997, Pages 181-188

  Sabri, O ^a   Erkwoh, R ^a   Schreckenberger, M ^a   Cremerius, U ^a   Schulz, G ^a   Dickmann, C ^a   Kaiser, H J ^a   Steinmeyer, E M ^a   Sass, H ^a   Buell, U ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

neuroleptic treatment; schizophrenia; SPECT; technetium 99m HMPAO

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; DELUSION; FEMALE; HALLUCINATION; HUMAN; MALE; NEUROANATOMY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEREOTYPY; THOUGHT DISORDER;

ADULT; ANTIPSYCHOTIC AGENTS; BRAIN; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; MALE; OBSERVER VARIATION; ORGANOTECHNETIUM COMPOUNDS; OXIMES; REGIONAL BLOOD FLOW; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; STATISTICS; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031038806     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Brodie JD, Christman DR, Corona JF, et al. Patterns of metabolic activity in the treatment of schizophrenia. Ann Neurol 1984;15:166-169.
2. Buchsbaum MS, Ingvar DH, Kessler R, et al. Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia. Arch Gen Psychiatry 1982;39:251-259.
3. DeLisi LE, Buchsbaum MS, Holcomb HH, et al. Clinical correlates of decreased anteroposterior metabolic gradients in positron emission tomography of schizophrenic patients. Am J Psychiatry 1985;142:78-81.
4. Farkas T, Wolf AP, Jaeger J, Brodie JD, et al. Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study. Arch Gen Psychiatry 1984;41:293-300.
5. Ingvar DH, Franzén G. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatr Scand 1974;50:425-462.
6. 99mTc-HMPAO single-photon emission imaging in chronic schizophrenia. Psychol Med 1992;22:27-35.
7. Wolkin A, Jaeger J, Brodie JD, et al. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. Am J Psychiatry 1985;142:564-571.
8. Catafau AM, Parellada E, Lomeña FJ, et al. Prefrontal and temporal blood flow in schizophrenia. J Nucl Med 1994;35:935-941.
9. Cleghorn JM, Garnett ES, Nahmias C, et al. Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia. Psychiatry Res 1989;28:119-133.
10. Szechtman H, Nahmias C, Garnett ES, et al. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia. Arch Gen Psychiatry 1988;45:523-532.
11. Volkow ND, Brodie JD, Wolf AP, Angrist B, Russel J, Cancro R. Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration. J Neurol Neurosurg Psychiatry 1986;49:1199-1202.
12. Wiesel FA, Wik G, Sjögren I, Blomqvist G, Greitz T, Stone-Elander S. Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates. Acta Psychiatr Scand 1987;76:628-641.
13. Sheppard G, Manchanda R, Gruzelier J, et al. Oxygen-15 positron emission tomographic scanning jn predominantly never treated acute schizophrenic patients. Lancet 1983;2:1448-1452.
14. Devous MD Sr, Paulman RG, Herman J, et al. Single-photon tomography studies with schizophrenic patients. J Clin Exp Neuropsychol 1988;10:321-322.
15. Paulman RG, Devous MD Sr, Gregory RR, et al. Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function. Biol Psychiatry 1990;27:377-399.
16. Syed GMS, Barret JJ, Toone BK. What does rCBF SPECT offer in schizophrenia? Nucl Med Commun 1992;13:879-884.
17. American Psychiatric Association DSM-III-R. Diagnostic and statistical manual of mental disorders, 3rd revised ed. Washington DC: American Psychiatric Press; 1987.
18. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276.
19. Overall JE, Gorham DR, et al. The brief psychiatric rating scale. Psychol Rep 1962;10:799-812.
20. Kaiser HJ, Sabri O, Wagenknecht G, Lege B, Hellwig D, Büll U. A method of correlating and merging cerebral morphology and function by a special headholder. Nucl Med 1994;33:123-126.
21. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978;25:638-643.
22. Talairach J, Touroux P. Referentially oriented cerebral MRI anatomy. Atlas of stereotoxic anatomical correlations for gray and white matter. New York: Thieme; 1993.
23. Kretschmann HJ, Weinrich W. Clinical neuroanatomy and cranial diagnostic imaging, 2nd ed. New York: Thieme; 1991.
24. Kojima A, Matsumoto M, Takahashi M, et al. Effect of spatial resolution on SPECT quantification values. J Nucl Med 1989;30:508-514.
25. Sabri O, Hellwig D, Kaiser HJ, et al. Effects of morphological changes on perfusion and metabolism in cerebral microangiopathy. Nucl Med 1995;34:50-56.
26. Sachs L. Applied statistics, 6th ed. Berlin: Springer; 1984.
27. Bavry JLSTAT-Power. Statistical design analysis system. Scientific Software, Inc: 1991.
28. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65-70.
29. Volkow ND, Wolf AP, Brodie JD, Cancro R. Clinical interpretation of metabolic and neurochemical abnormalities in schizophrenic patients studied with positron-emission tomography. In: Volkow ND, Wolf AP, eds. Positron emission tomography in schizophrenia research. Washington DC: American Psychiatric Press; 1991:59-73.
30. Volkow ND, Wolf AP, Van Gelder P, et al. Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia. Am J Psychiatry 1987;144:151-158.
31. Wolkin A, Sanfilipo M, Wolf AP, et al. Negative symptoms and hypofrontality in chronic schizophrenia. Arch Gen Psychiatry 1992;49:959-965.
32. 99mTc-exametazime in unmedicated schizophrenic patients. Biol Psychiatry 1993;33:487-495.
33. Andreasen NC, Rezai K, Alliger R, et al. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Arch Cen Psychiatry 1992;49:943-958.
34. Gur RC, Resnick SM, Gur RC, et al. Regional brain function in schizophrenia. II. Repeated evaluation with positron emission tomography. Arch Gen Psychiatry 1987;44:126-129.
35. Liddle PF, Friston KJ, Frith CD, et al. Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry 1992;160:179-186.
36. Crow TJ. Temporal lobe asymmetries as the key to the etiology of schizophrenia. Schizophr Bull 1990;16:433-443.
37. Berman KF, Weinberger DR. Functional localization in the brain in schizophrenia. In: Tasman A. Goldfinger SM, eds. American Psychiatric Association review of psychiatry. Washington DC: American Psychiatric Press; 1991;10:25-29.
38. Buchsbaum MS. Positron emission tomography and regional brain metabolism in schizophrenia research. In: Volkow ND, Wolf AP, eds. Positron emission tomography in schizophrenia research. Washington DC: American Psychiatric Press; 1991:27-45.